Dr. Hendry directs all research and development at API. Dr. Hendry obtained a
Ph.D. in Organic Chemistry from Cornell University in 1970 and has held a number of
academic appointments including at Cornell University, The Pennsylvania State
University and the Medical College Of Georgia. He is currently Adjunct Professor in the Department of
Physiology and Endocrinology at the Medical College of Georgia and in the College Of Pharmacy at the University of Geogia. Dr. Hendry has spent the last 30 years performing research that has formed the basis for API's
technology and is the principal inventor on all API patents.
Edwin D. Bransome, Jr., M.D.
Chief Medical Officer
Dr. Bransome is responsible for clinical research in the areas of diabetes and
anti-obesity. Dr. Bransome obtained his MD from the Columbia College of
Physicians and Surgeons. He has specialized in endocrinology, diabetes and
internal medicine. He has held academic appointments at Scripps Clinic &
Research Foundation, MIT, Harvard, and is Professor of Medicine Emeritus at the
Medical College of Georgia. He is Past President and a member of the Board of
Trustees of the U.S. Pharmacopoeia.
Virendra B. Mahesh, Ph.D.
Director of Strategic Research Planning
Dr. Mahesh is responsible for long-term research planning and oversees all
biological testing. He directs projects in neuroscience, reproductive
endocrinology and oncology. Dr. Mahesh holds a Ph.D. in Organic Chemistry from
Delhi University, India and a D.Phil. in Biological Sciences from Oxford
University, England. In addition to his duties at API, Dr. Mahesh is the
editor-in-chief of the journal Biology of Reproduction. He is also Regents
Professor and Chairman Emeritus of the Department of Physiology and
Endocrinology and Robert B. Greenblatt Professor Emeritus of Endocrinology at
the Medical College of Georgia.
Doug Ewing, M.D.
Medical Director
Dr. Ewing is responsible for clinical research in the central nervous system.
Dr. Ewing obtained his medical degree from the Medical College of Georgia,
specializing in psychiatry. He has been in clinical practice in Augusta,
Georgia for close to 20 years and has been involved in API's research since
1985. Dr. Ewing is a co-investigator for several ongoing clinical trials
of psychotropic drugs. Dr. Ewing is a primary inventor on recent patent pending technology using nuclear receptor/DNA interactions for drug discovery.
Neil Sidell, Ph.D.
Associate Research Partner
Dr. Sidell oversees preclinical studies of new compounds at the
molecular and cellular level of activity. He received a Ph.D. in
Physics from the University of Oregon and then went on to join a
Radiation Oncology Training Program at the University of Illinois as a
postdoctoral fellow. Dr. Sidell was on the faculty in the Department of
Pathology and Laboratory Medicine at the University of California, Los
Angeles for 17 years before assuming his present position as Professor
of Gynecology and Obstetrics at Emory University.
Dr. Hendry directs all research and development at API. Dr. Hendry obtained a
Ph.D. in Organic Chemistry from Cornell University in 1970 and has held a number of
academic appointments including at Cornell University, The Pennsylvania State
University and the Medical College Of Georgia. He is currently Adjunct Professor in the Department of
Physiology and Endocrinology at the Medical College of Georgia and in the College Of Pharmacy at the University of Geogia. Dr. Hendry has spent the last 30 years performing research that has formed the basis for API's
technology and is the principal inventor on all API patents.
Dr. Bransome is responsible for clinical research in the areas of diabetes and
anti-obesity. Dr. Bransome obtained his MD from the Columbia College of
Physicians and Surgeons. He has specialized in endocrinology, diabetes and
internal medicine. He has held academic appointments at Scripps Clinic &
Research Foundation, MIT, Harvard, and is Professor of Medicine Emeritus at the
Medical College of Georgia. He is Past President and a member of the Board of
Trustees of the U.S. Pharmacopoeia.
Dr. Mahesh is responsible for long-term research planning and oversees all
biological testing. He directs projects in neuroscience, reproductive
endocrinology and oncology. Dr. Mahesh holds a Ph.D. in Organic Chemistry from
Delhi University, India and a D.Phil. in Biological Sciences from Oxford
University, England. In addition to his duties at API, Dr. Mahesh is the
editor-in-chief of the journal Biology of Reproduction. He is also Regents
Professor and Chairman Emeritus of the Department of Physiology and
Endocrinology and Robert B. Greenblatt Professor Emeritus of Endocrinology at
the Medical College of Georgia.
Dr. Ewing is responsible for clinical research in the central nervous system.
Dr. Ewing obtained his medical degree from the Medical College of Georgia,
specializing in psychiatry. He has been in clinical practice in Augusta,
Georgia for close to 20 years and has been involved in API's research since
1985. Dr. Ewing is a co-investigator for several ongoing clinical trials
of psychotropic drugs. Dr. Ewing is a primary inventor on recent patent pending technology using nuclear receptor/DNA interactions for drug discovery.
Dr. Sidell oversees preclinical studies of new compounds at the
molecular and cellular level of activity. He received a Ph.D. in
Physics from the University of Oregon and then went on to join a
Radiation Oncology Training Program at the University of Illinois as a
postdoctoral fellow. Dr. Sidell was on the faculty in the Department of
Pathology and Laboratory Medicine at the University of California, Los
Angeles for 17 years before assuming his present position as Professor
of Gynecology and Obstetrics at Emory University.
